Perturbation of BRMS1 interactome reveals pathways that impact cell migration
R. C. Zimmermann, M. E. Sardiu, C. A. Manton, M. S. Miah, C. A. Banks, M. K. Adams, D. C. Koestler, D. R. Hurst, M. D. Edmonds, M. P. Washburn, D. R. Welch
Abstract
Breast Cancer Metastasis Suppressor 1 (BRMS1) expression is associated with longer patient survival in multiple cancer types. Understanding BRMS1 functionality will provide insights into both mechanism of action and will enhance potential therapeutic development. In this study, we confirmed that the C-terminus of BRMS1 is critical for metastasis suppression and hypothesized that critical protein interactions in this region would explain its function. Phosphorylation status at S237 regulates BRMS1 protein interactions related to a variety of biological processes, phenotypes [cell cycle (e.g., CDKN2A), DNA repair (e.g., BRCA1)], and metastasis [(e.g., TCF2 and POLE2)]. Presence of S237 also directly decreased MDA-MB-231 breast carcinoma migration in vitro and metastases in vivo. The results add significantly to our understanding of how BRMS1 interactions with Sin3/HDAC complexes regulate metastasis and expand insights into BRMS1s molecular role, as they demonstrate that BRMS1 C-terminus involvement in distinct direct protein-protein interactions.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Syndecan-1 facilitates breast cancer metastasis to the brain
M. R. Sayyad, M. Puchalapalli, … J. E. Koblinski·bioRxiv·Mar 5, 2019
- BMP-3b suppresses proliferation, migration, invasion, and TGF-β 1/Smad3 signaling in breast cancer cells
Tatsuki Yaginuma, Kana Mizuta, … Manabu Habu·bioRxiv·Jul 20, 2026
- BRK Phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG and metastatic potential.
S. Miah, C. Banks, … M. P. Washburn·bioRxiv·Dec 7, 2018
- Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis
A. G. Casanova, G. S. Roth, … N. Reynoird·bioRxiv·Sep 18, 2023
- TrkB induced metastatic potential of cancer by suppression of BMP mediated tumor inhibitory activity
- SMARCD1 is a "Goldilocks" metastasis modifier
Christina R. Ross, Li-Yun Gong, … Kent W. Hunter·Communications BiologyPeer-reviewed·Oct 10, 2024